RA CAPITAL MANAGEMENT, L.P. - 07 Jun 2022 Form 4 Insider Report for DICE Therapeutics, Inc.

Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
N/A
Transactions as of
07 Jun 2022
Net transactions value
$0
Form type
4
Filing time
08 Jun 2022, 17:30:30 UTC
Previous filing
07 Jun 2022
Next filing
09 Jun 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DICE Stock Option (Right to Buy) Award $0 +21,250 $0.000000 21,250 07 Jun 2022 Common Stock 21,250 $14.98 See footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F2 The shares subject to the option will vest on the earlier of: (i) the one-year anniversary of the grant date and (ii) the subsequent annual meeting of stockholders, subject to Mr. Jake Simson's, a Partner of the Adviser who serves on the Issuer's board of directors, continued service as a director.
F3 Under Mr. Simson's arrangement with the Adviser, Mr. Simson holds the option for the benefit of the Fund and the Nexus Fund II. Mr. Simson is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock except to the extent of their pecuniary interest.

Remarks:

Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors.